Aspirin response: Differences in serum thromboxane B2 levels between clinical studies. (Q41485945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Aspirin response: Differences in serum thromboxane B2 levels between clinical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Youssef Daali

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Charlotte Brun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Christophe Combescure

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Anne Zufferey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Alan D Michelson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pierre Fontana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Andrew L Frelinger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

13 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

196-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Aspirin response and failure in cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Development of aspirin resistance in persons with previous ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Paired analysis of urinary thromboxane B2 metabolites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Development of an enzyme-linked immunosorbent assay of thromboxane B2 using a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Aspirin and Other COX-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

Liquid chromatography–tandem mass spectrometry for simultaneous measurement of thromboxane B2 and 12(S)-hydroxyeicosatetraenoic acid in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2015.1072147

10.3109/09537104.2015.1072147

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270593%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference